Vandortuzumab vedotin

Modify Date: 2024-01-12 11:54:03

Vandortuzumab vedotin structure	Common Name	Vandortuzumab vedotin
	CAS Number	1471985-92-8	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Vandortuzumab vedotin

Vandortuzumab vedotin (DSTP 3086S) is an antibody-drug-conjugate to target prostate cancer[1].

Name	Vandortuzumab vedotin

Description	Vandortuzumab vedotin (DSTP 3086S) is an antibody-drug-conjugate to target prostate cancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker
References	[1]. Wout Oosterheert, et al. Structural basis for targeting human cancer antigen STEAP1 with antibodies. Journal of Biological Chemistry.

No Any Chemical & Physical Properties